)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
PW Medtech Group
PW Medtech Group (1358) investor relations material
PW Medtech Group H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary28 Aug, 2026
Executive summary
Operating revenue for H1 2026 was RMB394.1 million, down 4.9% year-over-year, mainly due to price declines in the Infusion Set Business from expanded centralized procurement.
Gross profit fell 10.8% to RMB189.9 million, with gross margin at 48.2%, down from 51.3% a year earlier.
Profit attributable to owners was RMB14.7 million, a 77.7% decrease year-over-year; adjusted profit attributable to owners was RMB31.3 million, down 62.5%.
Interim dividend declared at HK1.1 cents per share, compared to HK4.4 cents last year.
Financial highlights
Infusion Set Business revenue dropped 29.1% to RMB80.4 million due to price cuts from procurement policies.
Blood Purification Business revenue rose 3.7% to RMB308.5 million, driven by domestic demand.
Regenerative Medical Biomaterials Business revenue increased 46.3% to RMB5.2 million.
Operating profit decreased 54.9% to RMB36.2 million.
Net finance income fell 36.2% to RMB14.6 million.
Outlook and guidance
Focus remains on innovation-driven growth, optimizing product mix, and expanding R&D investment.
The Group aims to enhance competitiveness by targeting high-value products and expanding overseas, especially in blood purification.
Continued adaptation to centralized procurement and cost optimization are strategic priorities.
Will leverage technological leadership in regenerative biomaterials and expand sales network.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from PW Medtech Group
- Revenue up 7.1%, net profit down 29.7%, with strong cash and share buybacks amid margin pressure.1358
H2 2025 - Revenue up 22.4% on Blood Purification growth; profit to owners down 6.0%; interim dividend declared.1358H1 2025
- Revenue up 6.1% to RMB338.4m, profit down 1.1% to RMB70.2m, with strong blood purification growth.1358H1 2024
- Revenue up 13.9% with strong Blood Purification growth; adjusted profit rose 9.5%.1358H2 2024
Next PW Medtech Group earnings date
H2 202626 Mar, 2027
PW Medtech Group
Next PW Medtech Group earnings date
H2 202626 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
PW Medtech Group Limited is a medical device company that specializes in the research, development, manufacture, and distribution of healthcare products primarily for use in China. The company’s product portfolio focuses on infusion sets, wound care, and regenerative biomaterial solutions, serving hospitals and healthcare providers in a range of therapeutic areas. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.